Company Filing History:
Years Active: 1985
Title: Inventor Spotlight: Marta Sotinee Tolvay
Introduction
Marta Sotinee Tolvay is a distinguished inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceuticals, specifically focusing on sustained release compositions.
Latest Patents
Marta holds a patent for her invention titled "Sustained Release Pharmaceutical Compositions." This innovative formulation involves pharmaceutical compositions for the sustained release of active compounds. The patent details that it comprises a reaction product of a water-soluble salt of a pharmaceutically active compound containing a primary, secondary, or tertiary amino group, and an alkali or ammonium salt of a synthetic copolymer. The copolymers include combinations of methacrylic acid/methacrylic acid methyl ester and acrylic acid methyl ester, among others. The mixing of these components takes place in an aqueous medium, ultimately converting the product into a pharmaceutical composition.
Career Highlights
Marta has made a name for herself in the pharmaceutical industry through her role at Egyt Gyogyszervegyeszeti Gyar. Her groundbreaking patent reflects her dedication to improving drug formulations and enhances the effectiveness of pharmaceutical treatments.
Collaborations
Throughout her career, Marta has collaborated with other talented professionals, including her coworkers Erno Orban and Janos Borvendeg. Their collective efforts in research and development have contributed to advancements in pharmaceutical sciences, showcasing the importance of teamwork in innovation.
Conclusion
Marta Sotinee Tolvay's pioneering work in sustained release pharmaceutical compositions highlights her influence in the industry. Her patent represents a significant advancement in drug formulation technology, and her collaborations with experienced colleagues further exemplify the importance of innovation in the pharmaceutical field. With her continued contributions, Marta is set to inspire future developments in the sector.